Rivaroxaban (Xarelto) Picks Up New VTE Indication in Acutely Ill

The new indication provides an oral-only option for acutely ill medical patients, and is the eighth to date granted by the FDA to the direct oral anticoagulant.

Read the full article here

Related Articles